Error: Could not add to watchlist. X
+ Watchlist

Aegerion Pharmaceuticals Inc

AEGR:US
Acquired
AEGR:US was acquired by NVLN:CN
USD
Volume
0
52Wk Range
1.23 - 6.41
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
52Wk Range
1.23 - 6.41
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.66
Market Cap (USD)
-
Shares Outstanding (m)
29.545
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.43%
% Price Change
+0.39%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Address
101 Main Street
Suite 1850
Cambridge, MA 02142
United States
Phone
1-617-500-7867
Show More